Searched over 200M research papers for "losartan images"
10 papers analyzed
These studies suggest that losartan has potential benefits in various conditions including cardiovascular diseases, PTSD, metabolic regulation, and atherosclerosis, but its effectiveness in reducing cardiac hypertrophy in hypertrophic cardiomyopathy is contested.
20 papers analyzed
Losartan is a widely used angiotensin II receptor antagonist, primarily prescribed for treating hypertension and reducing the risk of stroke in patients with left ventricular hypertrophy (LVH). It functions by selectively blocking the angiotensin II type 1 receptors (AT1Rs), which play a crucial role in regulating the renin-angiotensin system (RAS).
Recent advancements have introduced novel losartan derivatives for positron emission tomography (PET) imaging, aimed at visualizing the distribution of AT1Rs. Two such derivatives, [18F]fluoroethyl-losartan ([18F]FEtLos) and [18F]ammoniomethyltrifluoroborate-losartan ([18F]AMBF3Los), have been synthesized and evaluated. Among these, [18F]AMBF3Los demonstrated a high binding affinity for AT1Rs and showed potential for specific binding in renal tissues, making it a promising tool for diagnosing cardiovascular, inflammatory, and cancer diseases.
Losartan has shown significant efficacy in reducing left ventricular hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy (HCM). Studies using cardiac magnetic resonance imaging (MRI) have indicated that losartan can attenuate the progression of myocardial hypertrophy and fibrosis, suggesting its potential role in managing HCM .
In patients with Marfan syndrome, losartan has been effective in reducing the rate of aortic root dilatation. This effect is particularly notable in patients who have undergone aortic root replacement, where losartan significantly reduced the dilatation rate of the aortic arch. However, comparisons with atenolol showed no significant differences in the progression of aortic root and ascending aorta diameters over a three-year follow-up period.
Losartan has also been found to improve insulin-mediated glucose uptake and non-oxidative glucose metabolism in insulin-resistant hypertensive patients. This improvement is attributed to increased blood flow and enhanced glucose metabolic clearance rates, highlighting losartan's role in managing metabolic conditions associated with hypertension.
Beyond its cardiovascular benefits, losartan has shown promise in neurocognitive applications. In a study investigating its effects on post-traumatic stress disorder (PTSD), losartan facilitated contextual processing and reduced autonomic stress responses during trauma exposure. These findings suggest potential mechanisms by which losartan could prevent PTSD symptomatology.
Losartan is a versatile medication with applications extending from cardiovascular and metabolic health to neurocognitive benefits. Its role in molecular imaging, particularly through novel PET tracers, opens new avenues for diagnosing and monitoring various diseases. As research continues, losartan's therapeutic potential across different medical fields is likely to expand, offering improved outcomes for patients with diverse health conditions.
Most relevant research papers on this topic